Intraperitoneal versus intravenous cisplatin in combination with intravenous cyclophosphamide and epidoxorubicin in optimally cytoreduced advanced epithelial ovarian cancer: A randomized trial of the Gruppo Oncologico Nord-Ovest

Angiolo Gadducci, Flavio Carnino, Silvana Chiara, Isa Brunetti, Lucia Tanganelli, Antonella Romanini, Milena Bruzzone, Pier Franco Conte

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Intraperitoneal versus intravenous cisplatin in combination with intravenous cyclophosphamide and epidoxorubicin in optimally cytoreduced advanced epithelial ovarian cancer: A randomized trial of the Gruppo Oncologico Nord-Ovest'. Together they form a unique fingerprint.

Medicine & Life Sciences